Radioterapia

Doença cardiovascular induzida por radiação: revisão de uma patologia sub-reconhecida.

12 Set, 2021 | 20:07h

Radiation‐Induced Cardiovascular Disease: Review of an Underrecognized Pathology – Journal of the American Heart Association

---

Diretrizes de prática clínica da ESMO adaptada para a Pan-Ásia para diagnóstico, tratamento e seguimento de pacientes com câncer de cólon localizado.

26 Ago, 2021 | 12:14h

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer – Annals of Oncology

---

Diretriz ASCO | Hipofunção de glândula salivar e/ou xerostomia induzida por terapias oncológicas não cirúrgicas.

19 Ago, 2021 | 12:12h

Salivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO Guideline – Journal of Clinical Oncology

---

Estudo randomizado de fase III sobre a irradiação cranial profilática (ICP) evitando-se ou não o hipocampo para câncer de pulmão de células pequenas (CPCP) – “Este estudo fornece a primeira evidência clínica de que evitar o hipocampo durante a ICP em pacientes com CPCP pode preservar a função cognitiva.”

13 Ago, 2021 | 12:05h

Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study – Journal of Clinical Oncology

---

Estudo randomizado | Eficácia da quimioterapia concomitante com S-1 vs. radioterapia isolada para pacientes idosos com câncer esofágico.

9 Ago, 2021 | 11:14h

Efficacy of Concurrent Chemoradiotherapy With S-1 vs Radiotherapy Alone for Older Patients With Esophageal Cancer: A Multicenter Randomized Phase 3 Clinical Trial – JAMA Oncology (gratuito por tempo limitado)

Editorial: Primary Chemoradiotherapy for Older Patients With Esophageal Cancer (gratuito por tempo limitado)

Comentário: Concurrent CRT Effective for Esophageal Cancer in Older Patients — Overall survival at 2 years significantly better versus radiotherapy alone – MedPage Today (necessário cadastro gratuito)

 

Comentário no Twitter

Randomized phase 3 trial of radiation with or w/o S-1 chemo in 298 older pts (median age 77) with esophageal cancer reveals concurrent chemoradiation led to significantly improved progression-free & overall survival https://t.co/wx5FG5VDUH #GICSM pic.twitter.com/SFddL53lCi

— JAMA Oncology (@JAMAOnc) August 6, 2021

 

---

Diretriz ASTRO | Radioterapia no tratamento de sarcoma de partes moles em adultos.

2 Ago, 2021 | 17:10h

Radiation Therapy for Treatment of Soft Tissue Sarcoma in Adults: Executive Summary of an ASTRO Clinical Practice Guideline – Practical Radiation Oncology

Comunicado de imprensa: Astro Issues Clinical Guideline on Radiation Therapy for Soft Tissue Sarcoma in Adults

---

Diretrizes ESMO | Sarcomas viscerais e de partes moles.

2 Ago, 2021 | 17:09h

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up – Annals of Oncology

---

Toxicidade associada a radioterapia: etiologia, tratamento e prevenção.

15 Jul, 2021 | 10:31h

Radiation therapy-associated toxicity: Etiology, management, and prevention – CA: A Cancer Journal for Clinicians

---

Câncer anal: Diretrizes de Prática Clínica da ESMO para diagnóstico, tratamento e seguimento.

1 Jul, 2021 | 10:10h

Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up – Annals of Oncology

 

Comentário no Twitter

Now available in Annals of Oncology, the @myESMO clinical practice guidelines for the diagnosis, treatment and follow-up of anal cancer, a rare disease accounting for less than 1% of all cancers https://t.co/usnFsd00BJ pic.twitter.com/bI0v60j8Ft

— Annals of Oncology (@Annals_Oncology) June 30, 2021

 

---

Resultados de longo prazo em estudo randomizado confirmam os benefícios da quimiorradioterapia neoadjuvante somada à cirurgia para câncer esofágico.

20 Mai, 2021 | 10:41h

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial – Journal of Clinical Oncology

 

Comentários no Twitter

Out at @ASCO_pubs
🔟yr Outcome of Neoadj #Chemoradiotherapy➕Surgery for #EsophagealCancer

☑️Show OS benefit in locally advanced resectable esophageal or junctional #Cancer who receive preop chemorad🧪☢️ According to CROSS, persists at least🔟years‼️https://t.co/yJSibSveAh pic.twitter.com/UssnzuFiEe

— Gil Morgan (@weoncologists) May 14, 2021

Survival benefit of preoperative chemoradiotherapy for patients with esophageal cancer persists – 10-year outcome of the CROSS trial https://t.co/s02sMVpYhI #esocsm #JCO @ErasmusMC @bmeyck pic.twitter.com/2JwV0iOvoB

— ASCO Publications (@ASCO_pubs) May 5, 2021

 

---